TCL Archive Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events June 28, 2013
TCL Archive FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines March 12, 1976